HiRM Symposium 2024
Dr. Heng will be presenting a poster, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer" at the 2024 Harvard Institute of RNA Medicine Symposium.
Search
Search results
6 results found
Regular aspirin use, breast tumor characteristics and long-term breast cancer survival
Peng, C, T Wang, MD Holmes, WY Chen, KD Brantley, PA Le, YJ Heng, et al. 2025. “Regular Aspirin Use, Breast Tumor Characteristics and Long-Term Breast Cancer Survival”. Npj Breast Cancer.
Reproductive factors and expression of stem cell markers in benign breast tissue
Wang, Tengteng, Yujing J. Heng, BR Sardella, BA Rosner, RM Tamimi, and Lusine Yaghjyan. 2024. “Reproductive Factors and Expression of Stem Cell Markers in Benign Breast Tissue”. Am J Can Res 14: 5434-45.
Associations of circulating insulin growth factor-1 and insulin growth factor binding protein-3 with the expression of stem cell markers in benign breast tissue
Yaghjyan, Lusine, Yujing J. Heng, BR Sardella, D Murty, MB Mahoney, BA Rosner, and RM Tamimi. 2025. “Associations of Circulating Insulin Growth Factor-1 and Insulin Growth Factor Binding Protein-3 With the Expression of Stem Cell Markers in Benign Breast Tissue”. Breast Cancer Res 27 (1): 53.
Extracellular vesicle-encapsulated miR-30c-5p reduces aging-related liver fibrosis.
Rodrigues, Alice Cristina, Yujing J Heng, and Frank J Slack. 2024. “Extracellular Vesicle-Encapsulated MiR-30c-5p Reduces Aging-Related Liver Fibrosis.”. Aging Cell 23: e14310.
Associations of stem cell markers with lobular involution in benign breast tissue
Yaghjyan, Lusine, RM Tamimi, GM Baker, and YJ Heng. 2025. “Associations of Stem Cell Markers With Lobular Involution in Benign Breast Tissue”. Cancer Epidemiol Biomarkers Prev 34 (8): 1314-21.